Azathioprine/leflunomide/rituximabCOVID-19: 3 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1971卷 / 1期

关键词：

D O I：

10.1007/s40278-023-45177-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：52 / 52

相关论文

共 50 条

[41] Prednisone/rituximabCOVID-19 pneumonia: case report [J].

Reactions Weekly, 2021, 1838 (1) :456-456

[42] Bendamustine/rituximabCOVID-19 pneumonia: case report [J].

Reactions Weekly, 2021, 1861 (1) :72-72

[43] Ocrelizumab/rituximabCOVID-19 infection [J].

Reactions Weekly, 2024, 2005 (1) :663-663

[44] RituximabCOVID-19 infection due to low anti-spike IgG antibodies: 2 case reports [J].

Reactions Weekly, 2023, 1968 (1) :270-270

[45] RituximabCovid-19 infection following exposure during pregnancy: case report [J].

Reactions Weekly, 2023, 1946 (1) :490-490

[46] RituximabCOVID-19 pneumonia and herpes simplex virus infection: case report [J].

Reactions Weekly, 2022, 1889 (1) :278-278

[47] Remdesivir/rituximabCOVID-19 infection and COVID-19 infection rebound: case report [J].

Reactions Weekly, 2022, 1927 (1) :461-461

[48] Prednisolone/rituximabCOVID-19 and SARS-CoV-2 pneumonia: case report [J].

Reactions Weekly, 2021, 1879 (1) :318-318

[49] COVID-19-vaccines/prednisolone/rituximabCOVID-19 pneumonia and lack of efficacy: case report [J].

Reactions Weekly, 2022, 1925 (1) :190-190

[50] Bendamustine/obinutuzumab/rituximabCOVID-19 infection and prolonged COVID-19 virus positivity: case report [J].

Reactions Weekly, 2022, 1922 (1) :134-134

← 1 2 3 4 5 →